BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3481758)

  • 1. Interaction of viral and cellular factors with the HTLV-III LTR target sequences in vitro.
    Heisig V; Benter T; Josephs SF; Sadaie MR; Okamoto T; Gallo RC; Wong-Staal F
    Haematol Blood Transfus; 1987; 31():423-9. PubMed ID: 3481758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.
    Rosen CA; Sodroski JG; Haseltine WA
    Cell; 1985 Jul; 41(3):813-23. PubMed ID: 2988790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription.
    Shimotohno K; Takano M; Teruuchi T; Miwa M
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8112-6. PubMed ID: 3022280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
    Derse D; Casey JW
    Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I.
    Fujisawa J; Seiki M; Sato M; Yoshida M
    EMBO J; 1986 Apr; 5(4):713-8. PubMed ID: 3011423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human T-cell leukemia virus type 1 gene expression by Sp1 and Sp3 interaction with TRE-1 repeat III.
    Yao J; Grant C; Harhaj E; Nonnemacher M; Alefantis T; Martin J; Jain P; Wigdahl B
    DNA Cell Biol; 2006 May; 25(5):262-76. PubMed ID: 16716116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide sequence analysis and enhancer function of long terminal repeats associated with an endogenous African green monkey retroviral DNA.
    Kessel M; Khan AS
    Mol Cell Biol; 1985 Jun; 5(6):1335-42. PubMed ID: 3861934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.
    Rosen CA; Sodroski JG; Kettman R; Haseltine WA
    J Virol; 1986 Mar; 57(3):738-44. PubMed ID: 3005624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis-acting transcriptional regulatory sequences in the gibbon ape leukemia virus (GALV) long terminal repeat.
    Holbrook NJ; Gulino A; Ruscetti F
    Virology; 1987 Mar; 157(1):211-9. PubMed ID: 3029959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat.
    Rosen CA; Sodroski JG; Haseltine WA
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6502-6. PubMed ID: 2995968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli.
    Kashanchi F; Wood C
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2157-61. PubMed ID: 2648391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.
    Sherman L; Yaniv A; Lichtman-Pleban H; Tronick SR; Gazit A
    J Virol; 1989 Nov; 63(11):4925-31. PubMed ID: 2552171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of endogenous feline leukemia virus long terminal repeats and adjoining regions.
    Berry BT; Ghosh AK; Kumar DV; Spodick DA; Roy-Burman P
    J Virol; 1988 Oct; 62(10):3631-41. PubMed ID: 2843665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a transactivating function mapping to the putative immediate-early locus of human herpesvirus 6.
    Martin ME; Nicholas J; Thomson BJ; Newman C; Honess RW
    J Virol; 1991 Oct; 65(10):5381-90. PubMed ID: 1654446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR.
    Seeler JS; Muchardt C; Podar M; Gaynor RB
    Virology; 1993 Oct; 196(2):442-50. PubMed ID: 8372429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor AP-2 activates gene expression of HTLV-I.
    Muchardt C; Seeler JS; Nirula A; Gong S; Gaynor R
    EMBO J; 1992 Jul; 11(7):2573-81. PubMed ID: 1628621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation.
    Hess JL; Small JA; Clements JE
    J Virol; 1989 Jul; 63(7):3001-15. PubMed ID: 2542608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor.
    Fujisawa J; Seiki M; Kiyokawa T; Yoshida M
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2277-81. PubMed ID: 2986109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus X gene can transactivate heterologous viral sequences.
    Twu JS; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2046-50. PubMed ID: 2538828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.